Eli Lilly and Novo Nordisk dominate the billion-dollar weight loss drug market. Lilly has announced positive trial results ...

Let's look at why this news could be a game-changer for Eli Lilly and its stock.

Eli Lilly is expanding its offerings of its ... with a syringe rather than the more expensive, easier to use auto-injector pens. A month’s supply of the auto-injector pens is about $1,086 ...

Eli Lilly and Co. is suing an Indianapolis-based weight-loss clinic it says is improperly selling Lilly’s hugely popular diabetes and weight-loss drugs.

Eli Lilly has launched new single-dose 2.5mg and 5.0mg vials of its obesity drug Zepbound in a move that it said would make it easier for people paying for the drug out-of-pocket to afford treatment.

A daily weight loss pill being tested by Eli Lilly could work as well as its GLP-1 injection counterparts like Ozempic, ...

(MENAFN- GlobeNewsWire - Nasdaq) Dublin, March 06, 2025 (GLOBE NEWSWIRE) -- The "Insulin Pens market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2036" report has been added ...

Eli Lilly weight loss drug ... Ozempic (semaglutide) is a brand-name injection pen used to treat type 2 diabetes. Meanwhile, Mounjaro (tirzepatide) is a brand-name subcutaneous injection pen ...

Objective: To assess the functionality and patient acceptability of HumaPen Ergo ®, a new 3.0ml reusable insulin pen. Design: Patients trialled HumaPen Ergo ® (Eli Lilly) over 5 to 7 weeks and ...